BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31734466)

  • 1. Risk factors associated with drug resistant focal epilepsy in adults: A case control study.
    Roy PL; Ronquillo LH; Ladino LD; Tellez-Zenteno JF
    Seizure; 2019 Dec; 73():46-50. PubMed ID: 31734466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting drug resistance in adult patients with generalized epilepsy: A case-control study.
    Voll A; Hernández-Ronquillo L; Buckley S; Téllez-Zenteno JF
    Epilepsy Behav; 2015 Dec; 53():126-30. PubMed ID: 26561950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validated outcome of treatment changes according to International League Against Epilepsy criteria in adults with drug-resistant focal epilepsy.
    Mula M; Zaccara G; Galimberti CA; Ferrò B; Canevini MP; Mascia A; Mecarelli O; Michelucci R; Pisani LR; Specchio LM; Striano S; Perucca E
    Epilepsia; 2019 Jun; 60(6):1114-1123. PubMed ID: 30866058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoresistance with newer anti-epileptic drugs in mesial temporal lobe epilepsy with hippocampal sclerosis.
    Pohlen MS; Jin J; Tobias RS; Maheshwari A
    Epilepsy Res; 2017 Nov; 137():56-60. PubMed ID: 28941835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment registry in focal epilepsy (TRIP): multicenter observational study in Lebanon.
    Beydoun A; Sawaya MT; Alam E; Hmaimess G; Ezzeddine K; Younes F
    Seizure; 2015 Apr; 27():54-9. PubMed ID: 25891928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal epilepsies in adult patients attending two epilepsy centers: classification of drug-resistance, assessment of risk factors, and usefulness of "new" antiepileptic drugs.
    Gilioli I; Vignoli A; Visani E; Casazza M; Canafoglia L; Chiesa V; Gardella E; La Briola F; Panzica F; Avanzini G; Canevini MP; Franceschetti S; Binelli S
    Epilepsia; 2012 Apr; 53(4):733-40. PubMed ID: 22360822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy.
    Geller EB; Skarpaas TL; Gross RE; Goodman RR; Barkley GL; Bazil CW; Berg MJ; Bergey GK; Cash SS; Cole AJ; Duckrow RB; Edwards JC; Eisenschenk S; Fessler J; Fountain NB; Goldman AM; Gwinn RP; Heck C; Herekar A; Hirsch LJ; Jobst BC; King-Stephens D; Labar DR; Leiphart JW; Marsh WR; Meador KJ; Mizrahi EM; Murro AM; Nair DR; Noe KH; Park YD; Rutecki PA; Salanova V; Sheth RD; Shields DC; Skidmore C; Smith MC; Spencer DC; Srinivasan S; Tatum W; Van Ness PC; Vossler DG; Wharen RE; Worrell GA; Yoshor D; Zimmerman RS; Cicora K; Sun FT; Morrell MJ
    Epilepsia; 2017 Jun; 58(6):994-1004. PubMed ID: 28398014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.
    Strozzi I; Nolan SJ; Sperling MR; Wingerchuk DM; Sirven J
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD001902. PubMed ID: 25922863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seizure outcome following medical treatment of mesial temporal lobe epilepsy: Clinical phenotypes and prognostic factors.
    Kuzmanovski I; Cvetkovska E; Babunovska M; Kiteva Trencevska G; Kuzmanovska B; Boshkovski B; Isjanovska R
    Clin Neurol Neurosurg; 2016 May; 144():91-5. PubMed ID: 27037863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic drug reduction and increased risk of stimulation-evoked focal to bilateral tonic-clonic seizure during cortical stimulation in patients with focal epilepsy.
    Hampel KG; Gómez-Ibáñez A; Garcés-Sánchez M; Hervás-Marín D; Cano-López I; González-Bono E; Conde-Sardón R; Gutiérrez-Martín A; Villanueva V
    Epilepsy Behav; 2018 Mar; 80():104-108. PubMed ID: 29414538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adult patients treated for focal epilepsy with antiepileptic drugs (AEDs) in combination in France: description according to the 2009 ILAE definition of AED resistance (ESPERA study)].
    Vespignani H; de Zélicourt M; Laurendeau C; Fagnani F; Levy-Bachelot L; Murat C; Kahane P; de Toffol B
    Rev Neurol (Paris); 2014 Feb; 170(2):100-9. PubMed ID: 24439556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of focal to bilateral tonic-clonic seizures during long-term video-EEG monitoring.
    Pensel MC; Schnuerch M; Elger CE; Surges R
    Epilepsia; 2020 Mar; 61(3):489-497. PubMed ID: 32068260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a third or later antiepileptic drug regimen according to epilepsy syndrome among adult patients.
    Ito G; Okumura A; Kanemoto K
    Epilepsy Res; 2017 Oct; 136():103-108. PubMed ID: 28822307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of seizure relapse after antiepileptic drug withdrawal in adult patients with focal epilepsy.
    He RQ; Zeng QY; Zhu P; Bao YX; Zheng RY; Xu HQ
    Epilepsy Behav; 2016 Nov; 64(Pt A):233-238. PubMed ID: 27764734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-responsive versus drug-refractory mesial temporal lobe epilepsy: a single-center prospective outcome study.
    Stefanatou M; Gatzonis S; Peskostas A; Paraskevas G; Koutroumanidis M
    Postgrad Med; 2019 Sep; 131(7):479-485. PubMed ID: 31513436
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-resistant epilepsy in adults: Outcome trajectories after failure of two medications.
    Choi H; Hayat MJ; Zhang R; Hirsch LJ; Bazil CW; Mendiratta A; Kato K; Javed A; Legge AW; Buchsbaum R; Resor S; Heiman GA
    Epilepsia; 2016 Jul; 57(7):1152-60. PubMed ID: 27265407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seizure outcome after AED failure in pediatric focal epilepsy: impact of underlying etiology.
    Wirrell EC; Wong-Kisiel LC; Nickels KC
    Epilepsy Behav; 2014 May; 34():20-4. PubMed ID: 24681380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yield of Brain MRI in Clinically Diagnosed Epilepsy in the Kingdom of Bhutan: A Prospective Study.
    Bruno V; Klein JP; Nidup D; Nirola DK; Tshering L; Deki S; Clark SJ; Linn KA; Shinohara RT; Dorji C; Pokhrel DR; Dema U; Mateen FJ;
    Ann Glob Health; 2017; 83(3-4):415-422. PubMed ID: 29221514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ZONISAMIDE: FIRST CHOICE AMONG THE FIRST-LINE ANTIEPILEPTIC DRUGS IN FOCAL EPILEPSY].
    Janszky J; Horvath R; Komoly S
    Ideggyogy Sz; 2015 May; 68(5-6):149-53. PubMed ID: 26182605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
    Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
    Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.